Implementation of Apnoea Test for Patients With Suspected Brain Death
Launched by KISKUNHALAS SEMMELWEIS HOSPITAL THE TEACHING HOSPITAL OF THE UNIVERSITY OF SZEGED · Apr 8, 2024
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how intensive care physicians currently perform the apnoea test for patients who are suspected of being brain dead. The apnoea test helps determine if a person has lost all brain function and is a critical step in confirming brain death. The researchers want to gather information from doctors in intensive care units about their practices and experiences with this important test.
To participate in this study, doctors who work in intensive care units will be asked to complete a survey. There are no specific age or gender requirements for the doctors, but they must be actively working in these units. This trial is not yet recruiting participants, so it's still in the planning stages. By collecting this information, the study aims to improve the understanding and application of the apnoea test, which could ultimately help in making more informed decisions about patient care in these challenging situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Physicians working in intensive care units
- Exclusion Criteria:
- • -
About Kiskunhalas Semmelweis Hospital The Teaching Hospital Of The University Of Szeged
Kiskunhalas Semmelweis Hospital, affiliated with the University of Szeged, is a leading teaching hospital in Hungary dedicated to advancing healthcare through clinical research and education. As a prominent clinical trial sponsor, the hospital integrates cutting-edge medical practices with academic rigor, fostering an environment that supports innovative therapies and patient-centered care. With a commitment to scientific excellence and collaboration, the institution plays a pivotal role in the advancement of medical knowledge and the improvement of patient outcomes, leveraging its extensive expertise to conduct high-quality clinical trials across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported